Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.

P Borchmann
, A Engert
, A Pluetschow
, M Fuchs
, J Markova
, A Lohri
, Z Kral
, Richard Greil
, M Topp
, M Villalobos
, J Zijlstra
, M Soekler
, H Stein
, HT Eich
, RP Mueller
, V Diehl

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to conference › Poster

1 Abstract (Journal)

1 results

2008

Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.
Borchmann, P., Engert, A., Pluetschow, A., Fuchs, M., Markova, J., Lohri, A., Kral, Z., Greil, R., Topp, M., Villalobos, M., Zijlstra, J., Soekler, M., Stein, H., Eich, H., Mueller, R. & Diehl, V., 2008, In: BLOOD . 112, 11, p. 367
Research output: Contribution to journal › Abstract (Journal) › peer-review